Total Payments
$2,853
2024 Payments
$807.24
Companies
22
Transactions
114
Medicare Patients
4,384
Medicare Billing
$181,287
Payment Breakdown by Category
Food & Beverage$2,853 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,853 | 114 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $387.29 | 18 | $0 (2024) |
| Amgen Inc. | $300.65 | 11 | $0 (2024) |
| Novo Nordisk Inc | $295.12 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $247.76 | 7 | $0 (2024) |
| Lilly USA, LLC | $224.54 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $177.38 | 7 | $0 (2024) |
| Exact Sciences Corporation | $166.78 | 8 | $0 (2024) |
| Stryker Corporation | $160.14 | 1 | $0 (2023) |
| PFIZER INC. | $147.54 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $114.21 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $807.24 | 37 | Amgen Inc. ($175.38) |
| 2023 | $1,230 | 46 | ABBVIE INC. ($312.02) |
| 2022 | $369.44 | 16 | Lilly USA, LLC ($139.46) |
| 2021 | $446.80 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($133.51) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Biological | ||||||
| 10/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: Biological | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Inflammation | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: DIABETES | ||||||
| 07/23/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Achondroplasia | ||||||
| 07/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Diabetes Care | ||||||
| 07/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.17 | General |
| 07/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Oncology | ||||||
| 06/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: Biological | ||||||
| 05/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Biological | ||||||
| 05/29/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/28/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/23/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: PSYCHIATRY | ||||||
| 05/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,106 | 1,627 | $180,487 | $53,186 |
| 2022 | 23 | 1,211 | 1,864 | $187,780 | $53,089 |
| 2021 | 20 | 836 | 1,187 | $121,591 | $36,386 |
| 2020 | 22 | 1,231 | 1,944 | $164,460 | $38,626 |
Total Patients
4,384
Total Services
6,622
Medicare Billing
$181,287
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 346 | $77,850 | $24,590 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 94 | 94 | $32,054 | $10,246 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 110 | $16,830 | $6,073 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $9,666 | $2,250 | 23.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 62 | 75 | $5,325 | $1,235 | 23.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 87 | 143 | $1,287 | $1,201 | 93.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 73 | 142 | $10,650 | $1,190 | 11.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 60 | 70 | $4,480 | $1,035 | 23.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 51 | 62 | $3,534 | $813.44 | 23.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 61 | 74 | $3,330 | $765.90 | 23.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 67 | 84 | $2,772 | $639.24 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,275 | $514.08 | 40.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 24 | 27 | $2,646 | $470.40 | 17.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 17 | 17 | $1,003 | $372.30 | 37.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 39 | $1,599 | $371.28 | 23.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 11 | 12 | $1,500 | $348.12 | 23.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 42 | 49 | $490.00 | $260.15 | 53.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 16 | 17 | $1,071 | $244.97 | 22.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 68 | 100 | $1,000 | $220.00 | 22.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 15 | 19 | $684.00 | $157.51 | 23.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 37 | 91 | $637.00 | $100.83 | 15.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $804.00 | $87.93 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 351 | $78,975 | $26,058 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 197 | $30,141 | $9,069 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 64 | 64 | $21,824 | $7,096 | 32.5% |
About Michelle Double
Michelle Double is a Primary Care healthcare provider based in Belleview, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2018. The National Provider Identifier (NPI) number assigned to this provider is 1902393002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Double has received a total of $2,853 in payments from pharmaceutical and medical device companies, with $807.24 received in 2024. These payments were reported across 114 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,853).
As a Medicare-enrolled provider, Double has provided services to 4,384 Medicare beneficiaries, totaling 6,622 services with total Medicare billing of $181,287. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Location Belleview, FL
- Active Since 04/16/2018
- Last Updated 05/29/2018
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1902393002
Products in Payments
- VRAYLAR (Drug) $303.41
- Otezla (Drug) $219.37
- JARDIANCE (Drug) $208.15
- Cologuard Collection Kit (Device) $166.78
- MAKO (Device) $160.14
- Veozah (Drug) $152.61
- ELIQUIS (Drug) $116.37
- MOUNJARO (Drug) $115.06
- Kerendia (Drug) $114.21
- QUVIVIQ (Drug) $98.29
- Ozempic (Drug) $95.82
- Repatha (Biological) $81.28
- ENTRESTO (Drug) $72.64
- NEXLIZET (Drug) $63.08
- REXULTI (Drug) $57.55
- Wegovy (Drug) $53.95
- Vascepa (Drug) $48.95
- EMGALITY (Drug) $48.19
- NEXLETOL (Drug) $45.40
- QULIPTA (Drug) $44.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.